Thompson Davis & Co., Inc. Co Diagnostics, Inc. Transaction History
Thompson Davis & Co., Inc.
- $132 Million
- Q3 2024
A detailed history of Thompson Davis & Co., Inc. transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 41,500 shares of CODX stock, worth $32,370. This represents 0.04% of its overall portfolio holdings.
Number of Shares
41,500
Previous 41,500
-0.0%
Holding current value
$32,370
Previous $51,000
-0.0%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.28MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.39 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$442,8230.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$391,5790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$250,5940.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$212,8620.01% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $26.3M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...